PH23727A - Imidazolylethoxyindanes and use as antithrombotic agents - Google Patents

Imidazolylethoxyindanes and use as antithrombotic agents

Info

Publication number
PH23727A
PH23727A PH33094A PH33094A PH23727A PH 23727 A PH23727 A PH 23727A PH 33094 A PH33094 A PH 33094A PH 33094 A PH33094 A PH 33094A PH 23727 A PH23727 A PH 23727A
Authority
PH
Philippines
Prior art keywords
imidazolylethoxyindanes
antithrombotic agents
antithrombotic
agents
Prior art date
Application number
PH33094A
Other languages
English (en)
Inventor
Rafael Foguet
Ernesto Forne
Jose A Ortiz
Aurelio Sacristan
Jose M Castello
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of PH23727A publication Critical patent/PH23727A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH33094A 1984-12-10 1985-11-26 Imidazolylethoxyindanes and use as antithrombotic agents PH23727A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES539074A ES8601148A1 (es) 1984-12-10 1984-12-10 Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.

Publications (1)

Publication Number Publication Date
PH23727A true PH23727A (en) 1989-11-03

Family

ID=8488410

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33094A PH23727A (en) 1984-12-10 1985-11-26 Imidazolylethoxyindanes and use as antithrombotic agents

Country Status (8)

Country Link
US (1) US4610998A (no)
EP (1) EP0184809B1 (no)
JP (1) JPS61155372A (no)
CA (1) CA1261852A (no)
DE (1) DE3571978D1 (no)
ES (1) ES8601148A1 (no)
PH (1) PH23727A (no)
ZA (1) ZA859034B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08993B2 (ja) * 1987-03-17 1996-01-10 川崎製鉄株式会社 金属ストリツプの電解処理装置
ZA981080B (en) 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
AU2004323810B2 (en) * 2004-10-08 2011-11-17 Suven Life Sciences Limited Novel intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
CA2757471A1 (en) * 2009-04-08 2010-10-14 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
CN102627543A (zh) * 2012-03-29 2012-08-08 常熟市新港农产品产销有限公司 5-羟基茚满酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
ES539074A0 (es) 1985-11-16
US4610998A (en) 1986-09-09
EP0184809A1 (en) 1986-06-18
JPS61155372A (ja) 1986-07-15
DE3571978D1 (en) 1989-09-07
JPH0338268B2 (no) 1991-06-10
ES8601148A1 (es) 1985-11-16
ZA859034B (en) 1986-08-27
EP0184809B1 (en) 1989-08-02
CA1261852A (en) 1989-09-26

Similar Documents

Publication Publication Date Title
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
DE3666855D1 (en) Alcalisilicate compositions and their use
GB8614549D0 (en) Contrast agents
GB8613493D0 (en) Diester-dtpa-paramagnetic contrast agents
EP0167363A3 (en) Crosslinked glycosaminoglycans and their use
ZA863957B (en) Alfuzosine compositions and use
EP0177158A3 (en) Thickening agents and the manufacture and use thereof
ZA855467B (en) Pickling agent
PH24451A (en) New pteridines and their use as pharmaceuticla agents
ZA859339B (en) Processes and compositions
CS1004884A1 (en) Hydraulicke zarizeni s lanovym pohonem
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
EP0181267A3 (en) Fibrinolysis-enhancing agents
ZA853379B (en) Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents
EP0255801A3 (en) Anilinotriazines and their use
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
GB2169508B (en) Ophthalmic compositions and use
ZA855612B (en) N-arylsulfonyl-n'-triazinylureas and n-arylsulfonyl-n'-pyrimidinyl-ureas
DE3471652D1 (en) Diurethane-diureas and use
PH23727A (en) Imidazolylethoxyindanes and use as antithrombotic agents
AU568750B2 (en) Imidazo-pyrrolo-pyridines and their use as herbacides
GB8415105D0 (en) Sealing-curing agent
GB8500101D0 (en) Flocculating agent
GB8529238D0 (en) Agents